title: Nosocomial infections: new therapeutic alternatives.
abstract: This symposium on nosocomial infections, antimicrobial resistance and the benefits of doripenem in this setting was held in Madrid, Spain, on 7 October 2009, and was supported by Janssen-Cilag. The topic was presented under an interdisciplinary approach by different international experts in the field.
authors.affiliation: Janssen-Cilag, Spain.
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Buron
authors.forename: Gian Maria
authors.initials: GM
authors.lastname: Rossolini
authors.forename: Santiago Grau
authors.initials: SG
authors.lastname: Cerrato
authors.forename: Jordi
authors.initials: J
authors.lastname: Rello
authors.forename: Rafael
authors.initials: R
authors.lastname: Zaragoza
authors.forename: José Angel García
authors.initials: JA
authors.lastname: Rodriguez
authors.forename: Javier
authors.initials: J
authors.lastname: Garau
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D015780:Carbapenems / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy*; D000077726:Doripenem; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D016032:Randomized Controlled Trials as Topic
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D000077726:Doripenem